NEW YORK - Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
NYSE:
Lowe's Companies Inc. (
NYSE:LOW,
Stock Forum), up 12 cents to $45.80
With housing prices soaring and late payments on mortgages hitting five-year lows, Canaccord Genuity boosted its ratings and target price on the home improvement retailer. Shares hit an all-time high of $46.25.
Krispy Kreme Doughnuts Inc., (
NYSE:KKD,
Stock Forum) up $1.12 to $22.52
Strong sales momentum at the doughnut chain earned an upgrade from Janney Capital Markets, which sees revenue coming in significantly stronger than it had initially expected.
Newmont Mining Corp., (
NYSE:NEM,
Stock Forum) up $1.39 to $30.90
Stocks in gold producers rally as the price of gold rebounds sharply. Gold prices rose 2 per cent to start the week, marking the fourth day of rising prices after new data suggested China's economic slowdown may be easing.
Sysco Corporation, (
NYSE:SYY,
Stock Forum) down $2.02 to $32.99
The food-distribution company's fourth-quarter net income fell 9 per cent, burdened by higher operating expenses and restructuring charges.
PharMerica Corp., (
NYSE:PMC,
Stock Forum) down 56 cents to $13.52
Shares in the pharmaceutical services company slump after the U.S. sues it for allegedly dispensing drugs without prescriptions. PharMerica said it “disputes the premises'' of the lawsuit and is vowing to defend itself.
NASDAQ:
Tesla Motors Inc., (
NASDAQ:TSLA,
Stock Forum) down $5.62 to $147.38
After jumping more than 300 per cent this year, a number of industry watchers believe Tesla is red-lining. Lazard downgraded the company's stock and a weekend piece from Barron's warned of ``bubble trouble'' for the electric carmaker.
Galectin Therapeutics Inc., (
OBB:GALT,
Stock Forum) up $1.21 to $6.78
The drug developer's liver disease treatment, now in early stage clinical testing, gets fast track designation from the Food and Drug Administration. That means a lot less red tape and a lot more potential for a blockbuster.
F5 Networks Inc., (
NASDAQ:FFIV,
Stock Forum) up $2.82 to $92.70
The stock was upgraded to Overweight by Barclays, which sees ongoing momentum for the information technology, networking equipment and services company. Analyst Ben Reitzes said that even though shares have spiked 30 per cent since July 9, given the history of share movement, F5 is in the middle of an upward surge.